XML 52 R35.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2018
Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries [Abstract] |
Supplemental Condensed Consolidating Balance Sheet | SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET As of March 31, 2018
|  | SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Assets |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 40.7 |  |  | $ | — |  |  | $ | — |  |  | $ | 74.8 |  |  | $ | (5.6 | ) |  | $ | 109.9 |
Restricted cash |  | — |  |  | 0.7 |  |  | 29.2 |  |  | 4.2 |  |  | — |  |  | 34.1 |
Accounts receivable, net |  | — |  |  | 65.0 |  |  | 190.3 |  |  | 300.0 |  |  | (1.2 | ) |  | 554.1 |
Notes receivable, net |  | — |  |  | — |  |  | 115.2 |  |  | 17.0 |  |  | — |  |  | 132.2 |
Inventories |  | — |  |  | 28.0 |  |  | 91.2 |  |  | 135.4 |  |  | (23.4 | ) |  | 231.2 |
Prepaid expenses, deposits and other current assets |  | 11.7 |  |  | 63.5 |  |  | 95.4 |  |  | 80.3 |  |  | (1.2 | ) |  | 249.7 |
Property and equipment, net |  | 26.9 |  |  | 94.8 |  |  | 228.1 |  |  | 182.6 |  |  | (27.1 | ) |  | 505.3 |
Investment in subsidiaries |  | 3,063.8 |  |  | 902.7 |  |  | 1,106.4 |  |  | — |  |  | (5,072.9 | ) |  | — |
Goodwill |  | — |  |  | 240.2 |  |  | 1,886.0 |  |  | 1,246.3 |  |  | — |  |  | 3,372.5 |
Intangible assets, net |  | 13.3 |  |  | 34.7 |  |  | 1,299.0 |  |  | 556.0 |  |  | — |  |  | 1,903.0 |
Intercompany balances |  | — |  |  | 5,832.2 |  |  | — |  |  | — |  |  | (5,832.2 | ) |  | — |
Software, net |  | 65.0 |  |  | 31.0 |  |  | 180.3 |  |  | 51.5 |  |  | — |  |  | 327.8 |
Other assets(2) |  | 234.7 |  |  | 421.1 |  |  | 54.5 |  |  | 214.6 |  |  | (607.5 | ) |  | 317.4 |
Total assets |  | $ | 3,456.1 |  |  | $ | 7,713.9 |  |  | $ | 5,275.6 |  |  | $ | 2,862.7 |  |  | $ | (11,571.1 | ) |  | $ | 7,737.2 |
Liabilities and stockholders' (deficit) equity |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt |  | $ | — |  |  | $ | 41.7 |  |  | $ | — |  |  | $ | 8.7 |  |  | $ | — |  |  | $ | 50.4 |
Other current liabilities |  | 87.8 |  |  | 180.0 |  |  | 230.7 |  |  | 245.3 |  |  | (37.9 | ) |  | 705.9 |
Long-term debt, excluding current portion |  | — |  |  | 8,791.4 |  |  | — |  |  | 2.6 |  |  | — |  |  | 8,794.0 |
Other long-term liabilities |  | 128.3 |  |  | 30.9 |  |  | 620.9 |  |  | 202.3 |  |  | (599.4 | ) |  | 383.0 |
Intercompany balances |  | 5,436.1 |  |  | — |  |  | 59.7 |  |  | 336.4 |  |  | (5,832.2 | ) |  | — |
Stockholders' (deficit) equity |  | (2,196.1 | ) |  | (1,330.1 | ) |  | 4,364.3 |  |  | 2,067.4 |  |  | (5,101.6 | ) |  | (2,196.1 | )
Total liabilities and stockholders' (deficit) equity |  | $ | 3,456.1 |  |  | $ | 7,713.9 |  |  | $ | 5,275.6 |  |  | $ | 2,862.7 |  |  | $ | (11,571.1 | ) |  | $ | 7,737.2 |
(1) Issuer of obligations under the 2020 Notes, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the Unsecured Notes, the 2025 Secured Notes, which were issued in October 2017, and the 2026 Secured Euro Notes and 2026 Unsecured Euro Notes, which were issued in February 2018. (2) Includes $15.0 million and $0.7 million in non-current restricted cash for Guarantor Subsidiaries and Non-Guarantor Subsidiaries, respectively.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET As of December 31, 2017
|  | SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Assets |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 732.6 |  |  | $ | — |  |  | $ | — |  |  | $ | 59.4 |  |  | $ | (3.2 | ) |  | $ | 788.8 |
Restricted cash |  | — |  |  | 0.6 |  |  | 28.3 |  |  | 0.1 |  |  | — |  |  | 29.0 |
Accounts receivable, net |  | 0.4 |  |  | 68.1 |  |  | 192.6 |  |  | 279.8 |  |  | — |  |  | 540.9 |
Notes receivable, net |  | — |  |  | — |  |  | 121.1 |  |  | 22.4 |  |  | — |  |  | 143.5 |
Inventories |  | — |  |  | 40.7 |  |  | 91.8 |  |  | 131.8 |  |  | (21.2 | ) |  | 243.1 |
Prepaid expenses, deposits and other current assets |  | 6.5 |  |  | 30.3 |  |  | 41.6 |  |  | 52.7 |  |  | — |  |  | 131.1 |
Property and equipment, net |  | 28.8 |  |  | 91.5 |  |  | 295.6 |  |  | 179.9 |  |  | (27.6 | ) |  | 568.2 |
Investment in subsidiaries |  | 3,098.7 |  |  | 867.9 |  |  | 987.7 |  |  | — |  |  | (4,954.3 | ) |  | — |
Goodwill |  | — |  |  | 240.3 |  |  | 1,880.4 |  |  | 835.4 |  |  | — |  |  | 2,956.1 |
Intangible assets, net |  | 15.7 |  |  | 34.9 |  |  | 1,335.3 |  |  | 218.7 |  |  | — |  |  | 1,604.6 |
Intercompany balances |  | — |  |  | 5,889.8 |  |  | — |  |  | 222.5 |  |  | (6,112.3 | ) |  | — |
Software, net |  | 67.2 |  |  | 24.7 |  |  | 199.0 |  |  | 48.5 |  |  | — |  |  | 339.4 |
Other assets(2) |  | 234.4 |  |  | 388.8 |  |  | 62.0 |  |  | 270.3 |  |  | (574.9 | ) |  | 380.6 |
Total assets |  | $ | 4,184.3 |  |  | $ | 7,677.6 |  |  | $ | 5,235.4 |  |  | $ | 2,321.5 |  |  | $ | (11,693.5 | ) |  | $ | 7,725.3 |
Liabilities and stockholders' (deficit) equity |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt |  | $ | — |  |  | $ | 32.8 |  |  | $ | — |  |  | $ | 7.5 |  |  | $ | — |  |  | $ | 40.3 |
Other current liabilities |  | 67.6 |  |  | 199.0 |  |  | 254.2 |  |  | 206.4 |  |  | (27.7 | ) |  | 699.5 |
Long-term debt, excluding current portion |  | — |  |  | 8,733.0 |  |  | — |  |  | 3.3 |  |  | — |  |  | 8,736.3 |
Other long-term liabilities |  | 68.8 |  |  | 11.3 |  |  | 650.3 |  |  | 110.9 |  |  | (565.1 | ) |  | 276.2 |
Intercompany balances |  | 6,074.9 |  |  | — |  |  | 37.4 |  |  | — |  |  | (6,112.3 | ) |  | — |
Stockholders' (deficit) equity |  | (2,027.0 | ) |  | (1,298.5 | ) |  | 4,293.5 |  |  | 1,993.4 |  |  | (4,988.4 | ) |  | (2,027.0 | )
Total liabilities and stockholders' (deficit) equity |  | $ | 4,184.3 |  |  | $ | 7,677.6 |  |  | $ | 5,235.4 |  |  | $ | 2,321.5 |  |  | $ | (11,693.5 | ) |  | $ | 7,725.3 |
(1) Issuer of obligations under the 2020 Notes, the 2021 Notes, the 2022 Secured Notes, the 2025 Secured Notes and the Unsecured Notes. (2) Includes $16.1 million and $0.7 million in non-current restricted cash for Guarantor Subsidiaries and Non-Guarantor Subsidiaries, respectively.
Supplemental Condensed Consolidating Statement of Income | SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME Three Months Ended March 31, 2018
|  | SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Revenue |  | $ | — |  |  | $ | 129.6 |  |  | $ | 386.9 |  |  | $ | 368.9 |  |  | $ | (73.6 | ) |  | $ | 811.8 |
Cost of services, cost of product sales and cost of instant products (2) |  | — |  |  | 86.3 |  |  | 118.4 |  |  | 153.1 |  |  | (61.1 | ) |  | 296.7 |
SG&A |  | 37.8 |  |  | 10.9 |  |  | 57.4 |  |  | 78.8 |  |  | (13.3 | ) |  | 171.6 |
R&D |  | — |  |  | 0.4 |  |  | 22.9 |  |  | 30.5 |  |  | — |  |  | 53.8 |
D&A |  | 9.2 |  |  | 7.6 |  |  | 126.1 |  |  | 48.4 |  |  | (3.2 | ) |  | 188.1 |
Restructuring and other |  | 26.1 |  |  | 0.8 |  |  | 1.5 |  |  | 23.8 |  |  | — |  |  | 52.2 |
Operating (loss) income |  | (73.1 | ) |  | 23.6 |  |  | 60.6 |  |  | 34.3 |  |  | 4.0 |  |  | 49.4 |
Interest expense |  | — |  |  | (154.4 | ) |  | — |  |  | (0.4 | ) |  | — |  |  | (154.8 | )
Loss on debt financing transactions |  | — |  |  | (93.2 | ) |  | — |  |  | — |  |  | — |  |  | (93.2 | )
Other income (expense), net |  | 15.6 |  |  | 136.1 |  |  | (132.9 | ) |  | (15.8 | ) |  | — |  |  | 3.0 |
Net (loss) income before equity in income of subsidiaries and income taxes |  | (57.5 | ) |  | (87.9 | ) |  | (72.3 | ) |  | 18.1 |  |  | 4.0 |  |  | (195.6 | )
Equity in (loss) income of subsidiaries |  | (83.9 | ) |  | 3.6 |  |  | 10.4 |  |  | — |  |  | 69.9 |  |  | — |
Income tax (expense) benefit |  | (60.4 | ) |  | 33.2 |  |  | 25.3 |  |  | (4.3 | ) |  | — |  |  | (6.2 | )
Net (loss) income |  | $ | (201.8 | ) |  | $ | (51.1 | ) |  | $ | (36.6 | ) |  | $ | 13.8 |  |  | $ | 73.9 |  |  | $ | (201.8 | )
Other comprehensive income |  | 52.1 |  |  | (17.1 | ) |  | 22.4 |  |  | 73.1 |  |  | (78.4 | ) |  | 52.1 |
Comprehensive (loss) income |  | $ | (149.7 | ) |  | $ | (68.2 | ) |  | $ | (14.2 | ) |  | $ | 86.9 |  |  | $ | (4.5 | ) |  | $ | (149.7 | )
(1) Issuer of obligations under the 2020 Notes, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the Unsecured Notes, the 2025 Secured Notes, which were issued in October 2017, and the 2026 Secured Euro Notes and 2026 Unsecured Euro Notes, which were issued in February 2018. (2) Exclusive of D&A.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Three Months Ended March 31, 2017
|  | SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Revenue |  | $ | — |  |  | $ | 118.0 |  |  | $ | 399.8 |  |  | $ | 264.6 |  |  | $ | (57.0 | ) |  | $ | 725.4 |
Cost of services, cost of product sales and cost of instant products (2) |  | — |  |  | 82.9 |  |  | 123.7 |  |  | 121.8 |  |  | (48.4 | ) |  | 280.0 |
SG&A |  | 29.7 |  |  | 9.5 |  |  | 48.8 |  |  | 62.4 |  |  | (9.7 | ) |  | 140.7 |
R&D |  | 0.5 |  |  | 1.4 |  |  | 34.2 |  |  | 6.3 |  |  | — |  |  | 42.4 |
D&A |  | 20.3 |  |  | 7.5 |  |  | 111.9 |  |  | 27.8 |  |  | (2.4 | ) |  | 165.1 |
Restructuring and other |  | 3.8 |  |  | 0.2 |  |  | 4.2 |  |  | 1.0 |  |  | — |  |  | 9.2 |
Operating (loss) income |  | (54.3 | ) |  | 16.5 |  |  | 77.0 |  |  | 45.3 |  |  | 3.5 |  |  | 88.0 |
Interest expense |  | (4.5 | ) |  | (154.6 | ) |  | — |  |  | (0.3 | ) |  | — |  |  | (159.4 | )
Loss on early extinguishment of debt |  | (1.1 | ) |  | (28.6 | ) |  | — |  |  | — |  |  | — |  |  | (29.7 | )
Other (expense) income, net |  | (20.8 | ) |  | 50.7 |  |  | (25.5 | ) |  | 12.6 |  |  | — |  |  | 17.0 |
Net (loss) income before equity in income of subsidiaries and income taxes |  | (80.7 | ) |  | (116.0 | ) |  | 51.5 |  |  | 57.6 |  |  | 3.5 |  |  | (84.1 | )
Equity in income of subsidiaries |  | 4.7 |  |  | 17.3 |  |  | 15.4 |  |  | — |  |  | (37.4 | ) |  | — |
Income tax (expense) benefit |  | (24.8 | ) |  | 43.4 |  |  | (20.6 | ) |  | (14.7 | ) |  | — |  |  | (16.7 | )
Net (loss) income |  | $ | (100.8 | ) |  | $ | (55.3 | ) |  | $ | 46.3 |  |  | $ | 42.9 |  |  | $ | (33.9 | ) |  | $ | (100.8 | )
Other comprehensive (loss) income |  | 36.1 |  |  | 4.0 |  |  | 21.5 |  |  | 29.5 |  |  | (55.0 | ) |  | 36.1 |
Comprehensive (loss) income |  | $ | (64.7 | ) |  | $ | (51.3 | ) |  | $ | 67.8 |  |  | $ | 72.4 |  |  | $ | (88.9 | ) |  | $ | (64.7 | )
(1) Issuer of obligations under the 2020 Notes, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the Unsecured Notes and the 2025 Secured Notes, which were issued in October 2017. (2) Exclusive of D&A.
Supplemental Condensed Consolidating Statement of Cash Flows | SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS Three Months Ended March 31, 2018
|  | SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Net cash (used in) provided by operating activities |  | $ | (32.0 | ) |  | $ | (25.4 | ) |  | $ | 34.3 |  |  | $ | 55.4 |  |  | $ | (2.4 | ) |  | $ | 29.9 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Capital expenditures |  | (7.9 | ) |  | (17.1 | ) |  | (44.5 | ) |  | (18.5 | ) |  | — |  |  | (88.0 | )
Acquisitions of businesses and assets, net of cash acquired |  | — |  |  | — |  |  | (9.6 | ) |  | (264.5 | ) |  | — |  |  | (274.1 | )
Distributions of capital from equity investments |  | — |  |  | — |  |  | — |  |  | 1.5 |  |  | — |  |  | 1.5 |
Other, principally change in intercompany investing activities |  | — |  |  | 74.0 |  |  | — |  |  | — |  |  | (74.0 | ) |  | — |
Net cash (used in) provided by investing activities |  | (7.9 | ) |  | 56.9 |  |  | (54.1 | ) |  | (281.5 | ) |  | (74.0 | ) |  | (360.6 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |
Proceeds net of payments on long-term debt |  | — |  |  | 7.1 |  |  | — |  |  | (1.8 | ) |  | — |  |  | 5.3 |
Repayment of assumed NYX debt |  | — |  |  | — |  |  | — |  |  | (288.2 | ) |  | — |  |  | (288.2 | )
Payments of debt issuance and deferred financing costs |  | — |  |  | (38.5 | ) |  | — |  |  | — |  |  | — |  |  | (38.5 | )
Payments on license obligations |  | (6.5 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (6.5 | )
Net redemptions of common stock under stock-based compensation plans and other |  | (15.9 | ) |  | — |  |  | (1.8 | ) |  | — |  |  | — |  |  | (17.7 | )
Other, principally change in intercompany financing activities |  | (629.6 | ) |  | — |  |  | 21.9 |  |  | 533.7 |  |  | 74.0 |  |  | — |
Net cash (used in) provided by financing activities |  | (652.0 | ) |  | (31.4 | ) |  | 20.1 |  |  | 243.7 |  |  | 74.0 |  |  | (345.6 | )
Effect of exchange rate changes on cash, cash equivalents and restricted cash |  | — |  |  | — |  |  | — |  |  | 1.9 |  |  | — |  |  | 1.9 |
(Decrease) increase in cash, cash equivalents and restricted cash |  | (691.9 | ) |  | 0.1 |  |  | 0.3 |  |  | 19.5 |  |  | (2.4 | ) |  | (674.4 | )
Cash, cash equivalents and restricted cash, beginning of period |  | 732.6 |  |  | 0.6 |  |  | 43.9 |  |  | 60.2 |  |  | (3.2 | ) |  | 834.1 |
Cash, cash equivalents and restricted cash end of period |  | $ | 40.7 |  |  | $ | 0.7 |  |  | $ | 44.2 |  |  | $ | 79.7 |  |  | $ | (5.6 | ) |  | $ | 159.7 |
(1) Issuer of obligations under the 2020 Notes, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the Unsecured Notes, the 2025 Secured Notes, which were issued in October 2017, and the 2026 Secured Euro Notes and 2026 Unsecured Euro Notes, which were issued in February 2018.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS Three Months Ended March 31, 2017
|  | SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Net cash (used in) provided by operating activities |  | $ | (62.2 | ) |  | $ | (20.9 | ) |  | $ | 104.3 |  |  | $ | 94.3 |  |  | $ | (4.5 | ) |  | $ | 111.0 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Capital expenditures |  | (9.3 | ) |  | (4.7 | ) |  | (26.2 | ) |  | (21.1 | ) |  | — |  |  | (61.3 | )
Acquisition of business, net of cash acquired |  | — |  |  | — |  |  | (21.5 | ) |  | — |  |  | — |  |  | (21.5 | )
Distributions of capital from equity investments |  | — |  |  | — |  |  | — |  |  | 1.3 |  |  | — |  |  | 1.3 |
Changes in other assets and liabilities and other |  | — |  |  | — |  |  | — |  |  | 2.0 |  |  | — |  |  | 2.0 |
Other, principally change in intercompany investing activities |  | — |  |  | (221.9 | ) |  | — |  |  | (60.6 | ) |  | 282.5 |  |  | — |
Net cash used in investing activities |  | (9.3 | ) |  | (226.6 | ) |  | (47.7 | ) |  | (78.4 | ) |  | 282.5 |  |  | (79.5 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |
Net payments of long-term debt including proceeds and repurchases of senior notes and term loans |  | (250.0 | ) |  | 274.0 |  |  | — |  |  | (1.5 | ) |  | — |  |  | 22.5 |
Payments of debt issuance and deferred financing costs |  | — |  |  | (27.2 | ) |  | — |  |  | — |  |  | — |  |  | (27.2 | )
Payments on license obligations |  | (9.2 | ) |  | — |  |  | (0.6 | ) |  | — |  |  | — |  |  | (9.8 | )
Net redemptions of common stock under stock-based compensation plans |  | (0.6 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (0.6 | )
Other, principally change in intercompany financing activities |  | 336.4 |  |  | — |  |  | (53.9 | ) |  | — |  |  | (282.5 | ) |  | — |
Net cash provided by (used in) financing activities |  | 76.6 |  |  | 246.8 |  |  | (54.5 | ) |  | (1.5 | ) |  | (282.5 | ) |  | (15.1 | )
Effect of exchange rate changes on cash, cash equivalents and restricted cash |  | — |  |  | — |  |  | — |  |  | 2.5 |  |  | — |  |  | 2.5 |
Increase (decrease) in cash, cash equivalents and restricted cash |  | 5.1 |  |  | (0.7 | ) |  | 2.1 |  |  | 16.9 |  |  | (4.5 | ) |  | 18.9 |
Cash, cash equivalents and restricted cash, beginning of period |  | 32.7 |  |  | 1.7 |  |  | 41.0 |  |  | 82.6 |  |  | (1.1 | ) |  | 156.9 |
Cash, cash equivalents and restricted cash end of period |  | $ | 37.8 |  |  | $ | 1.0 |  |  | $ | 43.1 |  |  | $ | 99.5 |  |  | $ | (5.6 | ) |  | $ | 175.8 |
(1) Issuer of obligations under the 2020 Notes, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the Unsecured Notes and the 2025 Secured Notes, which were issued in October 2017.

X
- Definition -- None. No documentation exists for this element. -- + References No definition available. + Details
Name: | sgms_FinancialInformationForGuarantorSubsidiariesAndNonGuarantorSubsidiariesAbstract
Namespace Prefix: | sgms_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration